Literature DB >> 10029531

Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization.

D Brömme1, Z Li, M Barnes, E Mehler.   

Abstract

Cathepsin V, a thymus and testis-specific human cysteine protease, was expressed in Pichia pastoris, and its physicokinetic properties were determined. Recombinant procathepsin V is autocatalytically activated at acidic pH and is effectively inhibited by various cysteine protease class-specific inhibitors. The S2P2 subsite specificity of cathepsin V was found to be intermediate between those of cathepsins S and L. The substrate binding pocket, S2, accepted both aromatic and nonaromatic hydrophobic residues, whereas cathepsins L and S preferred either an aromatic or nonaromatic hydrophobic residue, respectively. In contrast to cathepsin L, but similar to cathepsin S, cathepsin V exhibited only a very weak collagenolytic activity. Furthermore, cathepsin V was determined to be significantly more stable at mildly acidic and neutral pH than cathepsin L, but distinctly less stable than cathepsin S. A homology structure model of cathepsin V revealed completely different electrostatic potentials on the molecular surface when compared with human cathepsin L. The model-based electrostatic potential of human cathepsin V was neutral to weakly positive at and in the vicinity of the active site cleft, whereas that of cathepsin L was negative over extended regions of the surface. Surprisingly, the electrostatic potential of the human cathepsin V model structure resembled that of the model structure of mouse cathepsin L. These differences in the electrostatic potential at the molecular surfaces provide a reactivity determinant that may be the source of differences in substrate selectivity and pH stability. Cathepsin V was mapped to the chromosomal region 9q22.2, a site adjacent to the cathepsin L locus. The high sequence identity and the overlapping chromosomal gene loci suggest that both proteases evolved from an ancestral cathepsin L-like precursor by gene duplication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029531     DOI: 10.1021/bi982175f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  60 in total

Review 1.  Lysosomal cysteine proteases: facts and opportunities.

Authors:  V Turk; B Turk; D Turk
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  Nuclear cysteine cathepsin variants in thyroid carcinoma cells.

Authors:  Sofia Tedelind; Kseniia Poliakova; Amanda Valeta; Ruth Hunegnaw; Eyoel Lemma Yemanaberhan; Nils-Erik Heldin; Junichi Kurebayashi; Ekkehard Weber; Nataša Kopitar-Jerala; Boris Turk; Matthew Bogyo; Klaudia Brix
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

3.  Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.

Authors:  Valentina Zavasnik-Bergant; Ana Schweiger; Tadeja Bevec; Rastko Golouh; Vito Turk; Janko Kos
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

4.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

5.  Elastin degradation by cathepsin V requires two exosites.

Authors:  Xin Du; Nelson L H Chen; Andre Wong; Charles S Craik; Dieter Brömme
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

6.  PACMANS: A bioinformatically informed algorithm to predict, design, and disrupt protease-on-protease hydrolysis.

Authors:  Meghan C Ferrall-Fairbanks; Zachary T Barry; Maurizio Affer; Marc A Shuler; Ellen W Moomaw; Manu O Platt
Journal:  Protein Sci       Date:  2017-03-01       Impact factor: 6.725

7.  Cathepsin Protease Inhibition Reduces Endometriosis Lesion Establishment.

Authors:  Kristi M Porter; Friedrich A Wieser; Catera L Wilder; Neil Sidell; Manu O Platt
Journal:  Reprod Sci       Date:  2015-10-19       Impact factor: 3.060

8.  NF-kappaB protects from the lysosomal pathway of cell death.

Authors:  Ni Liu; Srikumar M Raja; Francesca Zazzeroni; Sunil S Metkar; Ramila Shah; Manling Zhang; Yue Wang; Dieter Brömme; William A Russin; Justine C Lee; Marcus E Peter; Christopher J Froelich; Guido Franzoso; Philip G Ashton-Rickardt
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

9.  Probing cathepsin K activity with a selective substrate spanning its active site.

Authors:  Fabien Lecaille; Enrico Weidauer; Maria A Juliano; Dieter Brömme; Gilles Lalmanach
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

10.  Stefin B interacts with histones and cathepsin L in the nucleus.

Authors:  Slavko Ceru; Spela Konjar; Katarina Maher; Urska Repnik; Igor Krizaj; Mojca Bencina; Miha Renko; Alain Nepveu; Eva Zerovnik; Boris Turk; Natasa Kopitar-Jerala
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.